Product Code: GVR-3-68038-839-8
Agricultural Biotechnology Market Growth & Trends:
The global agricultural biotechnology market size is anticipated to reach USD 212.57 billion by 2030 and is expected to grow at a CAGR of 7.1% from 2025 to 2030. Advent of unique genetic resources and genome modification tools is anticipated to enhance understanding of plant biology over the coming years. Additionally, a rise in demand for biofuel owing to depletion of conventional fuel is further projected to propel the market growth.
Penetration of genetic engineering tools has been recognized as a solution to overcome the pitfalls of conventional vaccine production. Genetically engineered vaccines have the potential of transforming the vaccine development scenario in the future. These products are continuously assessed by vaccine developing companies to understand the significance of recombinant vaccines in clinical as well as economical aspects which has made significant contributions to the revenue generated by vaccine development application segment in 2018.
Development of transgenic livestock is expected to immensely impact the improvement of nutrition, human health, animal welfare, reducing diseased livestock, and enhancing environmental protection. Moreover, genetic modification carried out in stem cells, livestock, and others are attributed to result in high-quality food and more yield from livestock. Some of the frequently adopted techniques for the development of transgenic animals include recombinant retroviruses, pronuclear Injection, sperm-mediated DNA transfer, embryonic stem cells, germ cell transplantation, and nuclear transfer "Cloning".
Agricultural Biotechnology Market Report Highlights:
- The plants segment led the market and accounted for the largest revenue share of 42.1% in 2024. This growth can be attributed to the increasing demand for crops that exhibit enhanced traits such as improved yield, pest resistance, and nutritional value.
- The transgenic crops and animals segment dominated the global agricultural biotechnology industry with the highest revenue share of 24.4% in 2024, driven by the increasing demand for enhanced agricultural productivity and sustainability.
- The vaccine development is expected to grow at a CAGR of 8.1% from 2025 to 2030, owing to the need for innovative solutions to combat animal diseases and improve livestock health.
- The Asia Pacific agricultural biotechnology market dominated the global market and accounted for the largest revenue share of 31.5% in 2024.
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definition
- 1.3. Information Procurement
- 1.3.1. Purchased Database
- 1.3.2. GVR's Internal Database
- 1.3.3. Secondary Sources & Third-Party Perspectives
- 1.3.4. Primary Research
- 1.4. Information Analysis
- 1.4.1. Data Analysis Models
- 1.5. Market Formulation & Data Visualization
- 1.6. Data Validation & Publishing
Chapter 2. Executive Summary
- 2.1. Market Insights
- 2.2. Segmental Outlook
- 2.3. Competitive Outlook
Chapter 3. Agricultural Biotechnology Market Variables, Trends & Scope
- 3.1. Global Agricultural Biotechnology Market Outlook
- 3.2. Industry Value Chain Analysis
- 3.3. Regulatory Framework
- 3.3.1. Policies and Incentive Plans
- 3.3.2. Standards and Compliances
- 3.3.3. Regulatory Impact Analysis
- 3.4. Market Dynamics
- 3.4.1. Market Driver Analysis
- 3.4.2. Market Restraint Analysis
- 3.4.3. Industry Challenges
- 3.5. Porter's Five Forces Analysis
- 3.5.1. Supplier Power
- 3.5.2. Buyer Power
- 3.5.3. Substitution Threat
- 3.5.4. Threat from New Entrant
- 3.5.5. Competitive Rivalry
- 3.6. PESTEL Analysis
- 3.6.1. Political Landscape
- 3.6.2. Economic Landscape
- 3.6.3. Social Landscape
- 3.6.4. Technological Landscape
- 3.6.5. Environmental Landscape
- 3.6.6. Legal Landscape
Chapter 4. Agricultural Biotechnology Market: Organism Outlook Estimates & Forecasts
- 4.1. Agricultural Biotechnology Market: Organism Movement Analysis, 2024 & 2030
- 4.1.1. Plants
- 4.1.1.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 4.1.1.2. Conventional Techniques
- 4.1.1.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 4.1.1.3. Established Genetic Modification
- 4.1.1.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 4.1.1.4. New Breeding Techniques
- 4.1.1.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 4.1.2. Animals
- 4.1.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 4.1.2.2. Conventional Techniques
- 4.1.2.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 4.1.2.3. Established Genetic Modification
- 4.1.2.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 4.1.2.4. New Breeding Techniques
- 4.1.2.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 4.1.3. Microbes
- 4.1.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 4.1.3.2. Conventional Techniques
- 4.1.3.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 4.1.3.3. Established Genetic Modification
- 4.1.3.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 4.1.3.4. New Breeding Techniques
- 4.1.3.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
Chapter 5. Agricultural Biotechnology Market: Application Outlook Estimates & Forecasts
- 5.1. Agricultural Biotechnology Market: Application Movement Analysis, 2024 & 2030
- 5.1.1. Vaccine Development
- 5.1.1.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 5.1.2. Transgenic Crops & Animals
- 5.1.2.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 5.1.3. Antibiotic Development
- 5.1.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 5.1.4. Nutritional Supplements
- 5.1.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 5.1.5. Flower Culturing
- 5.1.5.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 5.1.6. Biofuels
- 5.1.6.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
Chapter 6. Agricultural Biotechnology Market Regional Outlook Estimates & Forecasts
- 6.1. Regional Snapshot
- 6.2. Agricultural Biotechnology Market: Regional Movement Analysis, 2024 & 2030
- 6.3. North America
- 6.3.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 6.3.2. Market Estimates and Forecast, By Organism, 2018 - 2030 (USD Billion)
- 6.3.3. Market Estimates and Forecast, By Application, 2018 - 2030 (USD Billion)
- 6.3.4. U.S.
- 6.3.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 6.3.4.2. Market Estimates and Forecast, By Organism, 2018 - 2030 (USD Billion)
- 6.3.4.3. Market Estimates and Forecast, By Application, 2018 - 2030 (USD Billion)
- 6.3.5. Canada
- 6.3.5.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 6.3.5.2. Market Estimates and Forecast, By Organism, 2018 - 2030 (USD Billion)
- 6.3.5.3. Market Estimates and Forecast, By Application, 2018 - 2030 (USD Billion)
- 6.4. Europe
- 6.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 6.4.2. Market Estimates and Forecast, By Organism, 2018 - 2030 (USD Billion)
- 6.4.3. Market Estimates and Forecast, By Application, 2018 - 2030 (USD Billion)
- 6.4.4. Germany
- 6.4.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 6.4.4.2. Market Estimates and Forecast, By Organism, 2018 - 2030 (USD Billion)
- 6.4.4.3. Market Estimates and Forecast, By Application, 2018 - 2030 (USD Billion)
- 6.4.5. UK
- 6.4.5.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 6.4.5.2. Market Estimates and Forecast, By Organism, 2018 - 2030 (USD Billion)
- 6.4.5.3. Market Estimates and Forecast, By Application, 2018 - 2030 (USD Billion)
- 6.5. Asia Pacific
- 6.5.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 6.5.2. Market Estimates and Forecast, By Organism, 2018 - 2030 (USD Billion)
- 6.5.3. Market Estimates and Forecast, By Application, 2018 - 2030 (USD Billion)
- 6.5.4. Japan
- 6.5.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 6.5.4.2. Market Estimates and Forecast, By Organism, 2018 - 2030 (USD Billion)
- 6.5.4.3. Market Estimates and Forecast, By Application, 2018 - 2030 (USD Billion)
- 6.5.5. China
- 6.5.5.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 6.5.5.2. Market Estimates and Forecast, By Organism, 2018 - 2030 (USD Billion)
- 6.5.5.3. Market Estimates and Forecast, By Application, 2018 - 2030 (USD Billion)
- 6.6. Latin America
- 6.6.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 6.6.2. Market Estimates and Forecast, By Organism, 2018 - 2030 (USD Billion)
- 6.6.3. Market Estimates and Forecast, By Application, 2018 - 2030 (USD Billion)
- 6.6.4. Brazil
- 6.6.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 6.6.4.2. Market Estimates and Forecast, By Organism, 2018 - 2030 (USD Billion)
- 6.6.4.3. Market Estimates and Forecast, By Application, 2018 - 2030 (USD Billion)
- 6.7. Middle East & Africa
- 6.7.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 6.7.2. Market Estimates and Forecast, By Organism, 2018 - 2030 (USD Billion)
- 6.7.3. Market Estimates and Forecast, By Application, 2018 - 2030 (USD Billion)
- 6.7.4. South Africa
- 6.7.4.1. Market Estimates and Forecast, 2018 - 2030 (USD Billion)
- 6.7.4.2. Market Estimates and Forecast, By Organism, 2018 - 2030 (USD Billion)
- 6.7.4.3. Market Estimates and Forecast, By Application, 2018 - 2030 (USD Billion)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Vendor Landscape
- 7.2.1. Company Categorization
- 7.2.2. List of Key Distributors and Channel Partners
- 7.2.3. List of Potential Customers/End Users
- 7.3. Competitive Dynamics
- 7.3.1. Competitive Benchmarking
- 7.3.2. Strategy Mapping
- 7.3.3. Heat Map Analysis
- 7.4. Company Profiles/Listing
- 7.4.1. BASF SE
- 7.4.1.1. Participant's Overview
- 7.4.1.2. Financial Performance
- 7.4.1.3. Product Benchmarking
- 7.4.1.4. Strategic Initiatives
- 7.4.2. Bayer AG
- 7.4.2.1. Participant's Overview
- 7.4.2.2. Financial Performance
- 7.4.2.3. Product Benchmarking
- 7.4.2.4. Strategic Initiatives
- 7.4.3. ADAMA Agriculture Solution
- 7.4.3.1. Participant's Overview
- 7.4.3.2. Financial Performance
- 7.4.3.3. Product Benchmarking
- 7.4.3.4. Strategic Initiatives
- 7.4.4. Corteva
- 7.4.4.1. Participant's Overview
- 7.4.4.2. Financial Performance
- 7.4.4.3. Product Benchmarking
- 7.4.4.4. Strategic Initiatives
- 7.4.5. Syngenta
- 7.4.5.1. Participant's Overview
- 7.4.5.2. Financial Performance
- 7.4.5.3. Product Benchmarking
- 7.4.5.4. Strategic Initiatives
- 7.4.6. Evogene
- 7.4.6.1. Participant's Overview
- 7.4.6.2. Financial Performance
- 7.4.6.3. Product Benchmarking
- 7.4.6.4. Strategic Initiatives
- 7.4.7. DuPont
- 7.4.7.1. Participant's Overview
- 7.4.7.2. Financial Performance
- 7.4.7.3. Product Benchmarking
- 7.4.7.4. Strategic Initiatives
- 7.4.8. Vilmorin
- 7.4.8.1. Participant's Overview
- 7.4.8.2. Financial Performance
- 7.4.8.3. Product Benchmarking
- 7.4.8.4. Strategic Initiatives
- 7.4.9. Isagro SPA
- 7.4.9.1. Participant's Overview
- 7.4.9.2. Financial Performance
- 7.4.9.3. Product Benchmarking
- 7.4.9.4. Strategic Initiatives
- 7.4.10. Benson Hil
- 7.4.10.1. Participant's Overview
- 7.4.10.2. Financial Performance
- 7.4.10.3. Product Benchmarking
- 7.4.10.4. Strategic Initiatives